Literature DB >> 11552951

TNF-alpha-mediated multiplication of human immunodeficiency virus in chronically infected monocytoid cells by mycobacterial infection.

H Kitaura1, N Ohara, K Kobayashi, T Yamada.   

Abstract

Mycobacterial infection is a common occurrence in patients with acquired immune deficiency syndrome. Incubation of U1, a chronically HIV-1-infected human promonocytic cell line, with Mycobacterium smegmatis, M. avium, M. bovis BCG and M. tuberculosis resulted in enhancement of p24 antigen release in the supernatant, indicating that these mycobacteria could activate HIV replication from this cell line. The amount of p24 in the culture infected with M. smegmatis was higher than in cultures infected with other mycobacteria. The amounts of p24 release in cultures infected with M. avium and M. bovis BCG were intermediate. M. tuberculosis slightly stimulated HIV replication. The amount of TNF-alpha produced by U1 cells was correlated with the amount of p24 antigen release. The IL-1beta and IL-6 levels in the supernatant from cultures infected with all species were the same. The antibody to TNF-alpha inhibited p24 release induced by mycobacterial infections. The anti-IL-1beta and anti-IL-6 antibodies, however, scarcely influenced stimulation of HIV replication by mycobacterial infection. These data suggested that activation of HIV replication by mycobacteria mainly occurred by secondary release of cytokine TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11552951     DOI: 10.1111/j.1600-0463.2001.apm090707.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  6 in total

1.  HIV-1 reactivation induced by the periodontal pathogens Fusobacterium nucleatum and Porphyromonas gingivalis involves Toll-like receptor 2 [corrected] and 9 activation in monocytes/macrophages.

Authors:  Octavio A González; Mengtao Li; Jeffrey L Ebersole; Chifu B Huang
Journal:  Clin Vaccine Immunol       Date:  2010-07-07

Review 2.  Health impacts of environmental mycobacteria.

Authors:  Todd P Primm; Christie A Lucero; Joseph O Falkinham
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

Review 3.  Treatment Options for HIV-Associated Tuberculosis.

Authors:  Philip Chukwuka Onyebujoh; Isabela Ribeiro; Christopher Curtis Whalen
Journal:  J Infect Dis       Date:  2007-08-15       Impact factor: 5.226

4.  Immune Responses of HIV-1 Tat Transgenic Mice to Mycobacterium Tuberculosis W-Beijing SA161.

Authors:  Jennifer R Honda; Shaobin Shang; Crystal A Shanley; Megan L Caraway; Marcela Henao-Tamayo; Edward D Chan; Randall J Basaraba; Ian M Orme; Diane J Ordway; Sonia C Flores
Journal:  Open AIDS J       Date:  2011-10-19

5.  LMP-420, a small-molecule inhibitor of TNF-alpha, reduces replication of HIV-1 and Mycobacterium tuberculosis in human cells.

Authors:  Soichi Haraguchi; Noorbibi K Day; Wasu Kamchaisatian; Macarena Beigier-Pompadre; Steffen Stenger; Nutthapong Tangsinmankong; John W Sleasman; Salvatore V Pizzo; George J Cianciolo
Journal:  AIDS Res Ther       Date:  2006-03-31       Impact factor: 2.250

Review 6.  Co-infections as Modulators of Disease Outcome: Minor Players or Major Players?

Authors:  Priti Devi; Azka Khan; Partha Chattopadhyay; Priyanka Mehta; Shweta Sahni; Sachin Sharma; Rajesh Pandey
Journal:  Front Microbiol       Date:  2021-07-06       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.